Xi-Qi Xu

594 total citations
28 papers, 392 citations indexed

About

Xi-Qi Xu is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Xi-Qi Xu has authored 28 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pulmonary and Respiratory Medicine and 4 papers in Internal Medicine. Recurrent topics in Xi-Qi Xu's work include Pulmonary Hypertension Research and Treatments (14 papers), Viral Infections and Immunology Research (6 papers) and Cardiomyopathy and Myosin Studies (4 papers). Xi-Qi Xu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (14 papers), Viral Infections and Immunology Research (6 papers) and Cardiomyopathy and Myosin Studies (4 papers). Xi-Qi Xu collaborates with scholars based in China, United States and Australia. Xi-Qi Xu's co-authors include Xin Jiang, Zhi‐Cheng Jing, Yan Wu, Kai Sun, Fu-Hua Peng, Rong Jiang, Yuanqiang Zhang, Lan Wang, Qin‐Hua Zhao and Tian‐Yu Lian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Radiology and CHEST Journal.

In The Last Decade

Xi-Qi Xu

22 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi-Qi Xu China 10 195 179 123 45 40 28 392
Rika Suda Japan 12 266 1.4× 135 0.8× 102 0.8× 42 0.9× 44 1.1× 39 372
Adelheid Panzenboeck Austria 6 186 1.0× 148 0.8× 63 0.5× 34 0.8× 40 1.0× 10 377
Ayumi Sekine Japan 11 291 1.5× 145 0.8× 109 0.9× 44 1.0× 32 0.8× 36 401
Mirjam E. van Albada Netherlands 11 280 1.4× 171 1.0× 63 0.5× 67 1.5× 28 0.7× 16 401
Rintaro Nishimura Japan 14 360 1.8× 172 1.0× 160 1.3× 69 1.5× 42 1.1× 37 545
Guido P. L. Bossers Netherlands 8 173 0.9× 125 0.7× 110 0.9× 41 0.9× 42 1.1× 10 301
Diederik E. van der Feen Netherlands 10 286 1.5× 180 1.0× 139 1.1× 55 1.2× 44 1.1× 16 435
C. François France 3 290 1.5× 192 1.1× 64 0.5× 52 1.2× 20 0.5× 9 366
Richard Sultanian Canada 9 234 1.2× 108 0.6× 143 1.2× 92 2.0× 87 2.2× 23 453
Katsuya Kozu Japan 9 263 1.3× 198 1.1× 58 0.5× 40 0.9× 25 0.6× 16 350

Countries citing papers authored by Xi-Qi Xu

Since Specialization
Citations

This map shows the geographic impact of Xi-Qi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi-Qi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi-Qi Xu more than expected).

Fields of papers citing papers by Xi-Qi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi-Qi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi-Qi Xu. The network helps show where Xi-Qi Xu may publish in the future.

Co-authorship network of co-authors of Xi-Qi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xi-Qi Xu. A scholar is included among the top collaborators of Xi-Qi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi-Qi Xu. Xi-Qi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Anyi, Yue Cui, Chao Liu, et al.. (2025). Growth Differentiation Factor-15 Improves Prognostic Accuracy of Risk Stratification in Pulmonary Arterial Hypertension. CHEST Journal. 169(3). 758–768.
2.
Liu, Yutong, et al.. (2025). Research progress on the role of oxidative stress in the pathogenesis of vascular dementia and its treatment. Journal of Stroke and Cerebrovascular Diseases. 34(12). 108475–108475.
3.
4.
Lian, Tian‐Yu, Jianzhou Liu, Yu‐Ping Zhou, et al.. (2022). Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension. JACC Asia. 2(3). 247–255. 2 indexed citations
5.
Wu, Yanfang, Deyan Yang, Luxi Sun, et al.. (2022). Case report: Recurrent syncope as initial symptom in a patient with neck lymphoma. Frontiers in Cardiovascular Medicine. 9. 932798–932798.
6.
Xu, Xi-Qi, Tian Zheng, Quan Fang, Zhi‐Cheng Jing, & Yuanqiang Zhang. (2021). [Standard operation procedure of percutaneous endomyocardial biopsy in Peking Union Medical College Hospital].. PubMed. 49(1). 12–16. 2 indexed citations
7.
Li, Jinghui, Xi-Qi Xu, Yongjian Zhu, et al.. (2021). Subendocardial Involvement as an Underrecognized Cardiac MRI Phenotype in Myocarditis. Radiology. 302(1). 61–69. 13 indexed citations
8.
Zhu, Yongjian, Yu‐Ping Zhou, Yunpeng Wei, et al.. (2021). Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension. Frontiers in Cardiovascular Medicine. 8. 628284–628284. 7 indexed citations
9.
Tan, Jiang‐Shan, Xinxin Yan, Yan Wu, et al.. (2021). Rare variants in MTHFR predispose to occurrence and recurrence of pulmonary embolism. International Journal of Cardiology. 331. 236–242. 37 indexed citations
10.
11.
Wang, Xiaojian, Tian‐Yu Lian, Xin Jiang, et al.. (2018). GermlineBMP9mutation causes idiopathic pulmonary arterial hypertension. European Respiratory Journal. 53(3). 1801609–1801609. 90 indexed citations
12.
Xu, Xi-Qi, Qianqian Liu, Qin‐Hua Zhao, et al.. (2016). Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension. International Journal of Cardiology. 228. 895–899. 27 indexed citations
13.
Jiang, Xin, Fu-Hua Peng, Qianqian Liu, et al.. (2016). Optical coherence tomography for hypertensive pulmonary vasculature. International Journal of Cardiology. 222. 494–498. 9 indexed citations
14.
Xu, Xi-Qi, Ping Zhu, Qian Chen, et al.. (2016). Ankle-brachial index and brachial-ankle pulse wave velocity are associated with albuminuria in community-based Han Chinese. Clinical and Experimental Hypertension. 38(7). 618–623. 6 indexed citations
15.
Jiang, Xin, Yuefu Wang, Qin‐Hua Zhao, et al.. (2014). Acute hemodynamic response of infused fasudil in patients with pulmonary arterial hypertension: A randomized, controlled, crossover study. International Journal of Cardiology. 177(1). 61–65. 32 indexed citations
16.
Zhao, Qin‐Hua, Xi-Qi Xu, Zhi‐Cheng Jing, et al.. (2010). [Diagnosis value of electrocardiogram in patients with pulmonary artery hypertension].. PubMed. 38(4). 346–9. 2 indexed citations
17.
Wang, Shuxia, Chunyan Fu, Yubao Zou, et al.. (2008). Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy. Chinese Medical Journal. 121(1). 27–31. 29 indexed citations
18.
Hui, Rutai, Shuxia Wang, Yubao Zou, et al.. (2008). Worse Prognosis with Gene Mutations of Beta‐myosin Heavy Chain than Myosin‐Binding Protein C in Chinese Patients with Hypertrophic Cardiomyopathy. Clinical Cardiology. 31(3). 114–118. 28 indexed citations
19.
Jing, Zhi‐Cheng, Xi-Qi Xu, Yong Wang, et al.. (2008). [Effects of bosentan in treatment of pulmonary arterial hypertension: a pilot study of 21 patients].. PubMed. 88(30). 2136–9. 2 indexed citations
20.
Wang, Shuxia, Chunyan Fu, Hu Wang, et al.. (2007). Polymorphisms of the peroxisome proliferator-activated receptor-γ coactivator-1α gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy. Clinical Chemistry and Laboratory Medicine (CCLM). 45(8). 962–7. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rika Suda Breakdown of academic impact, for papers by Adelheid Panzenboeck Breakdown of academic impact, for papers by Ayumi Sekine Breakdown of academic impact, for papers by Mirjam E. van Albada Breakdown of academic impact, for papers by Rintaro Nishimura Breakdown of academic impact, for papers by Guido P. L. Bossers Breakdown of academic impact, for papers by Diederik E. van der Feen Breakdown of academic impact, for papers by C. François Breakdown of academic impact, for papers by Richard Sultanian Breakdown of academic impact, for papers by Katsuya Kozu
Rankless by CCL
2026